Alisan Kayabolen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Top Venues

Science advances

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Kaiyi Jiang, Justin Lim, Samantha R Sgrizzi, Michael Trinh, Alisan Kayabolen, Natalya Yutin, Weidong Bao, Kazuki Kato, Eugene V Koonin, Jonathan Samuel Gootenberg, Omar O Abudayyeh
Programmable RNA-guided DNA endonucleases are widespread in eukaryotes and their viruses. Science advances 9 (39) (2023)
Alisan Kayabolen, Ugur Akcan, Doğancan Özturan, Hivda Ulbeği Polat, Gizem Nur Sahin, Nareg Pinarbasi Degirmenci, Canan Bayraktar, Gizem Soyler, Ehsan Sarayloo, Elif Nurtop, Berna Özer, Gülen Esken, Tayfun Barlas, Ismail Selim Yildirim, Ozlem Dogan, Sercin Karahuseyinoglu, Nathan A Lack, Mehmet Kaya, Cem Albayrak, Füsun Can, Ihsan Solaroglu, Tugba Bagcı-Önder
Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (27) (2022)
Ozlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, Ali Cenk Aksu, Ayse Derya Cavga, Ahmet Cingöz, Ezgi Yagmur Kala, Goktug Karabiyik, Rauf Günsay, Beril Esin, Tunc Morova, Fırat Uyulur, Hamzah Syed, Martin Philpott, Adam P Cribbs, Sonia H Y Kung, Nathan A Lack, Tamer T Önder, Tugba Bagcı-Önder
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. Cell death & disease 13 (8) (2022)
Alisan Kayabolen, Ebru Yilmaz, Tugba Bagcı-Önder
IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications? Biomedicines 9 (7) (2021)